The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DeepVerge Collaboration for Water & Soil Analysis

23 Aug 2021 07:00

RNS Number : 3801J
Microsaic Systems plc
23 August 2021
 

 

RNS Reach

 

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic collaborates with DeepVerge plc to launch range of miniature mass spectrometers with triple quadrupole limits of detection for organic chemical analysis in water and soil

 

Combined micro-engineering technology, software and AI create unique identification detection system for Chemicals of Emerging Concern[i] (CEC) including Forever Chemicals[ii] (PFAS)

 

Microsaic (AIM:MSYS), is pleased to announce continued progress through its collaboration with DeepVerge plc ("DeepVerge") (AIM: DVRG) to provide real-time monitoring solutions to detect and identify contaminants in water and soil.

 

Microsaic has launched a miniaturised mass spectrometer platform which provides fully integrated front-end solutions, with software upgrades using AI from DeepVerge, to achieve triple quadrupole limits of detection for real-time monitoring and identification of organic chemicals in water and soil. 'Triple quad' limits of detection mean increased sensitivity and specificity, which allows detection and quantitation at lower limits than conventional single quadrupole mass spectroscopy.

 

In collaboration with DeepVerge plc environmental division, who has implemented real-time services for the automated detection and identification of metals and pathogens[iii], Microsaic augments this offering now with automated real-time detection and expert analysis of dangerous organic chemicals in water and soil.

 

· Detection capability for a variety of contaminants and toxic bad actors adds:

o Organic chemical expertise and detection of CECs, currently unregulated and unmeasured, with the European Chemical Agency in 2020 identifying 290 chemical candidates for regulatory action by the European Commission[iv]

· New platform augments revenue channels of both companies without re-engineering business infrastructure:

o Screening - project deployment (e.g. site remediation, clean up, chronic or acute spills), mobile laboratory/van etc.

o Monitoring - site surveillance (e.g. waste water treatment plants, sites of special interest)

· Retrofit or standalone integration of high-tech hardware, software and AI adds:

o Unified data handling

o Unified/integrated sampling strategies

o Unified front-end to customers installations and collaborations

o Powerful and accurate analysis of aggregated data with AI delivering the ability to detect an array of targets in a single platform and with predictive alert capability

 

The new portable Microsaic platform, with triple quadrupole limits of detection is unique, bringing laboratory quality performance to the front-line, at a fraction the cost and up to 90% smaller than traditional triple quadrupole mass spectrometry equipment, reducing workflows and allowing real-time manual, or automated, decision making in real-time.

 

Glenn Tracey, CEO of Microsaic Systems plc, commented:

"The Microsaic team has achieved two major milestones: first, a range of miniaturised portable mass spectrometry systems with triple quadrupole limits of detection, and second, access to potential new sources of shared income from monitoring services that offer protection to society against the silent killer of chemicals of emerging concern."

 

"This combination of capabilities from Microsaic and DeepVerge provides impressive coverage between chemicals and pathogens in our waters and soil. The Microsaic Board believes that data-driven monitoring capability is of great interest to government, industrial and agricultural stakeholders which is already generating significant interest from prospective clients."

 

 

Gerard Brandon, DeepVerge plc CEO, commented:

"By combining our expertise in contaminant monitoring, we are able to offer new, innovative real-time monitoring solutions to our existing customers and open new global opportunities for fully-integrated water and soil detection of a broad range of pathogens and chemicals. This includes detecting the presence of COVID-SARS-CoV-2, providing the potential to identify virus hotspots more rapidly and cost effectively than by direct human testing."

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking) 

Turner Pope Investments (TPI) Limited(Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

About Microsaic (www.microsaic.com)

 

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications. 

 

About DeepVerge plc (www.deepverge.com)

 

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 


[i] https://www.microsaic.com/news/the_truth_about_the_silent_undetected_killers_in_our_waters/

[ii] https://www.microsaic.com/news/5-enivronmental-issues-real-time-diagnosis-can-help-solve/

[iii] Pathogens (virus, bacteria, toxins and parasites)

[iv] https://echa.europa.eu/-/nearly-300-chemicals-identified-as-candidates-for-regulatory-action

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDICBDDGBG
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.